Imvexxy®(estradiol) Vaginal Inserts
Annual Sales
Company THERAPEUTICS MD
Date of First Filing December 30, 2019
Paragraph IV Applicant: Teva
Case Name: THERAPEUTICSMD INC v. TEVA PHARMACEUTICALS USA INC et al
Court/Case #: New Jersey District Court (njdc) 2:2020cv03485
Date Filed: 4/1/20
Judge: Martinotti
Product Strength: 4 mcg…[Read more]
The Paragraph Four Report®
Paragraph IV Activity for March 2020
New Certifications as reported by FDA on March 10, 2020
1. Bijuva®(estradiol and progesterone) Capsules 1 mg/100 mg on 1/6/2020
Comments: This is the sole product in March.
New Cases Filed
1. Product: Hetlioz®(tasimelteon) Capsules
Case: VANDA PHARMACEUTICALS INC v.…[Read more]
Firmagon®(degarelix) Powder for Injection
Annual Sales
Company FERRING
Date of First Filing December 20, 2019
Paragraph IV Applicant: Fresenius Kabi
Case Name: FERRING PHARMACEUTICALS INC et al v. FRESENIUS KABI USA LLC et al
Court/Case #: Delaware District Court (dedc) 1:2020cv00431
Date Filed: 3/26/2020
Judge:
Product…[Read more]
.
